tiprankstipranks
China Risun Group Ltd. (HK:1907)
:1907

China Risun Group Ltd. (1907) AI Stock Analysis

0 Followers

Top Page

HK:1907

China Risun Group Ltd.

(1907)

Select Model
Select Model
Select Model
Neutral 54 (OpenAI - 5.2)
Rating:54Neutral
Price Target:
HK$2.50
▲(11.61% Upside)
Action:ReiteratedDate:11/01/25
The overall stock score of 54 reflects the company's stable revenue growth but significant profitability challenges and high leverage. The technical analysis indicates a bearish trend, while the valuation is impacted by a negative P/E ratio. The dividend yield provides some support, but overall, the stock faces multiple headwinds.
Positive Factors
Improved free cash flow generation
A strong rise in free cash flow indicates the business is converting operations into cash despite profit pressure. Durable cash generation supports capex, working capital and debt servicing, providing flexibility to invest or de-lever over a 2-6 month horizon.
Negative Factors
High leverage
A D/E of 2.38 signals material reliance on debt financing. High leverage increases interest burden and reduces strategic flexibility, making the company vulnerable to earnings shocks and raising refinancing risk in a capital-intensive chemicals business over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
Improved free cash flow generation
A strong rise in free cash flow indicates the business is converting operations into cash despite profit pressure. Durable cash generation supports capex, working capital and debt servicing, providing flexibility to invest or de-lever over a 2-6 month horizon.
Read all positive factors

China Risun Group Ltd. (1907) vs. iShares MSCI Hong Kong ETF (EWH)

China Risun Group Ltd. Business Overview & Revenue Model

Company Description
China Risun Group Limited, together with its subsidiaries, produces, sells, and distributes coke, coking chemicals, and refined chemicals in the People's Republic of China. The company operates through four segments: Coke and Coking Chemicals Manu...
How the Company Makes Money
China Risun Group Ltd. generates revenue primarily through the production and sale of metallurgical coke and chemical products derived from coal. Key revenue streams include sales of coke to steel manufacturers, which constitutes a significant por...

China Risun Group Ltd. Financial Statement Overview

Summary
China Risun Group Ltd. demonstrates stable revenue growth but faces profitability challenges with a declining net profit margin. The balance sheet reveals high leverage, posing financial risks, though the equity ratio indicates a balanced asset structure. Cash flow generation shows improvement, reflecting operational resilience, but net income volatility remains a concern.
Income Statement
60
Neutral
Balance Sheet
55
Neutral
Cash Flow
65
Positive
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue42.88B47.54B46.07B43.14B39.37B19.78B
Gross Profit3.32B3.49B3.32B4.28B5.53B3.22B
EBITDA3.40B3.50B4.37B4.63B5.45B3.22B
Net Income-63.08M20.13M860.81M1.86B2.61B1.65B
Balance Sheet
Total Assets63.26B59.84B53.84B46.10B36.80B24.21B
Cash, Cash Equivalents and Short-Term Investments2.76B2.26B1.25B1.40B2.37B1.19B
Total Debt35.13B30.38B26.31B20.70B16.70B10.57B
Total Liabilities47.62B43.96B39.36B33.51B25.69B15.94B
Stockholders Equity12.57B12.76B12.90B12.11B10.98B8.13B
Cash Flow
Free Cash Flow2.46B-1.24B134.87M-1.22B534.69M-725.01M
Operating Cash Flow2.42B1.44B2.20B3.16B4.21B1.14B
Investing Cash Flow-7.05B-3.64B-1.71B-9.18B-5.13B-2.19B
Financing Cash Flow3.32B3.05B-455.15M4.93B2.02B1.16B

China Risun Group Ltd. Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price2.24
Price Trends
50DMA
2.86
Positive
100DMA
2.57
Positive
200DMA
2.50
Positive
Market Momentum
MACD
0.10
Positive
RSI
47.70
Neutral
STOCH
19.38
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1907, the sentiment is Neutral. The current price of 2.24 is below the 20-day moving average (MA) of 3.35, below the 50-day MA of 2.86, and below the 200-day MA of 2.50, indicating a neutral trend. The MACD of 0.10 indicates Positive momentum. The RSI at 47.70 is Neutral, neither overbought nor oversold. The STOCH value of 19.38 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for HK:1907.

China Risun Group Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
69
Neutral
HK$4.21B7.746.29%6.70%-3.73%6.09%
62
Neutral
HK$19.91B10.1811.90%0.98%-1.43%113.67%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
61
Neutral
HK$1.20B18.522.55%3.52%-5.29%-32.47%
59
Neutral
HK$1.24B7.697.36%2.20%-8.51%-68.34%
54
Neutral
HK$13.72B87.42-0.50%1.16%-15.17%-125.24%
52
Neutral
HK$5.78B8.077.70%9.20%213.87%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:1907
China Risun Group Ltd.
3.08
0.61
24.55%
HK:0609
Tiande Chemical Holdings Limited
1.37
0.39
39.80%
HK:1702
Dongguang Chemical Ltd.
1.99
0.50
33.56%
HK:0189
Dongyue Group Limited
12.02
3.92
48.40%
HK:2198
China Sanjiang Fine Chemicals Co., Ltd.
4.93
3.48
240.00%
HK:0746
Lee & Man Chemical Co. Ltd.
5.10
1.83
55.96%

China Risun Group Ltd. Corporate Events

China Risun Grants 4.5 Million Share Awards to 600 Employees Under Long-Term Incentive Plan
Jan 22, 2026
China Risun Group Limited has granted a total of 4,503,000 share awards at no purchase price to 600 Group employees under its share award plan adopted in 2025, with the grant made on 22 January 2026 at a reference closing price of HK$2.28 per shar...
China Risun Group Ltd. Provides $269.6M Guarantee for Joint Venture Financing
Dec 17, 2025
China Risun Group Ltd. has announced a provision of a guarantee in connection with a financing arrangement for its joint venture, Risun Wei Shan. The company, holding a 51% stake in the joint venture, has committed to guarantee up to US$269.6 mill...
China Risun Group Terminates Major Transaction with Binhai Energy
Nov 14, 2025
China Risun Group Limited has announced the termination of a proposed transaction involving the disposal of equity interests in Cangzhou Risun Chemicals Limited in exchange for shares from Tianjin Binhai Energy Development Co., Ltd. The terminati...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 01, 2025